Prophylaxis, Invasive Fungal Disease, and Neutropenic Children and Young Adults

To the Editor Dr Fisher and colleagues examined prevention of invasive fungal infections in neutropenic patients aged 3 months to 30 years with acute myeloid leukemia with caspofungin vs fluconazole. Caspofungin resulted in a statistically significant lower incidence of invasive fungal disease. However, prophylaxis depends on appropriateness and adequacy of the antifungal medication.
Source: JAMA - Category: General Medicine Source Type: research